Tayyab Sidra J, Adrada Beatriz E, Rauch Gaiane Margishvili, Yang Wei Tse
1 Diagnostic Radiology, University of Texas MD Anderson Cancer Center , Houston, TX , USA.
Br J Radiol. 2018 Dec;91(1092):20180213. doi: 10.1259/bjr.20180213. Epub 2018 Jul 31.
Fat necrosis of the breast is a well-described benign entity that can result in unnecessary biopsy of breast lesions. The pathogenesis of fat necrosis is a non-suppurative inflammatory process of adipose tissue, which may be seen after trauma, surgery, biopsy, post-breast reconstruction, post-fat grafting, post-radiotherapy, infection, and duct ectasia, among other conditions. Clinically, these patients may be asymptomatic or may present with a palpable lump, skin tethering, induration, and occasionally axillary lymphadenopathy. Depending on the time at which diagnostic imaging is performed, fat necrosis can have highly variable appearances on different modalities as it evolves. This is directly related to whether inflammation or fibrosis is predominating within the lesion, and correlation with clinical history is paramount in evaluating these patients. This review aims to analyze benign and suspicious imaging features of fat necrosis confirmed by tissue sampling. Knowledge of both benign and malignant-appearing features of fat necrosis on conventional modalities such as mammography and ultrasound, as well as newer applications including digital breast tomosynthesis, PET/CT, and MRI, should help the radiologist minimize the number of unnecessary biopsies.
乳腺脂肪坏死是一种已被充分描述的良性病变,可能导致对乳腺病变进行不必要的活检。脂肪坏死的发病机制是脂肪组织的非化脓性炎症过程,在创伤、手术、活检、乳房重建术后、脂肪移植术后、放疗后、感染及导管扩张等多种情况下均可出现。临床上,这些患者可能无症状,或可表现为可触及的肿块、皮肤粘连、硬结,偶尔伴有腋窝淋巴结肿大。根据进行诊断性成像检查的时间不同,脂肪坏死在其演变过程中在不同检查方式上可呈现出高度可变的表现。这直接与病变内炎症或纤维化何者占主导有关,在评估这些患者时,与临床病史的关联至关重要。本综述旨在分析经组织取样证实的脂肪坏死的良性及可疑影像学特征。了解脂肪坏死在传统检查方式(如乳腺钼靶和超声)以及包括数字乳腺断层合成、PET/CT和MRI在内的新应用中的良性及恶性表现特征,应有助于放射科医生减少不必要活检的数量。